PDE7B and Stroke: Also, dipyridamole, a 3′,5′-cyclic phosphodiesterase inhibitor, targets PDE7B and current clinical trials are testing therapies based on dipyridamole for diseases such as stroke, coronary heart disease, ischemia reperfusion injury, and internal carotid artery stenosis.